A201 EFFECT OF MIRIKIZUMAB ON BOWEL URGENCY CLINICALLY MEANINGFUL IMPROVEMENT AND REMISSION: RESULTS FROM THE PHASE 3 LUCENT INDUCTION AND MAINTENANCE STUDIES

BACKGROUND: Bowel urgency (BU) was assessed in mirikizumab (miri) Phase 3 LUCENT studies in moderately-to-severely active UC using the validated Urgency Numeric Rating Scale (UNRS). UNRS measures BU severity in the past 24 hours from 0 (no urgency) to 10 (worst possible urgency). Psychometric evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Travis, S, Hibi, T, Hisamatsu, T, Fisher, D, Shan, M, Gibble, T H, Rubin, D, Jones, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Poster Presentations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991375/
http://dx.doi.org/10.1093/jcag/gwac036.201

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9991375/
http://dx.doi.org/10.1093/jcag/gwac036.201

Ejemplares similares